IBDEI33P ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,49525,1,4,0)
 ;;=4^C79.82
 ;;^UTILITY(U,$J,358.3,49525,2)
 ;;=^267339
 ;;^UTILITY(U,$J,358.3,49526,0)
 ;;=C49.A2^^191^2467^1
 ;;^UTILITY(U,$J,358.3,49526,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49526,1,3,0)
 ;;=3^GIST,Stomach
 ;;^UTILITY(U,$J,358.3,49526,1,4,0)
 ;;=4^C49.A2
 ;;^UTILITY(U,$J,358.3,49526,2)
 ;;=^8148063
 ;;^UTILITY(U,$J,358.3,49527,0)
 ;;=I50.9^^191^2468^16
 ;;^UTILITY(U,$J,358.3,49527,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49527,1,3,0)
 ;;=3^Heart Failure,Unsp
 ;;^UTILITY(U,$J,358.3,49527,1,4,0)
 ;;=4^I50.9
 ;;^UTILITY(U,$J,358.3,49527,2)
 ;;=^5007251
 ;;^UTILITY(U,$J,358.3,49528,0)
 ;;=I73.9^^191^2468^22
 ;;^UTILITY(U,$J,358.3,49528,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49528,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,49528,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,49528,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,49529,0)
 ;;=I35.0^^191^2468^20
 ;;^UTILITY(U,$J,358.3,49529,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49529,1,3,0)
 ;;=3^Nonrheumatic Aortic Vlve Stenosis
 ;;^UTILITY(U,$J,358.3,49529,1,4,0)
 ;;=4^I35.0
 ;;^UTILITY(U,$J,358.3,49529,2)
 ;;=^5007174
 ;;^UTILITY(U,$J,358.3,49530,0)
 ;;=I35.1^^191^2468^19
 ;;^UTILITY(U,$J,358.3,49530,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49530,1,3,0)
 ;;=3^Nonrheumatic Aortic Vlve Insuff
 ;;^UTILITY(U,$J,358.3,49530,1,4,0)
 ;;=4^I35.1
 ;;^UTILITY(U,$J,358.3,49530,2)
 ;;=^5007175
 ;;^UTILITY(U,$J,358.3,49531,0)
 ;;=I35.2^^191^2468^21
 ;;^UTILITY(U,$J,358.3,49531,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49531,1,3,0)
 ;;=3^Nonrheumatic Aortic Vlve Stenosis w/ Insuff
 ;;^UTILITY(U,$J,358.3,49531,1,4,0)
 ;;=4^I35.2
 ;;^UTILITY(U,$J,358.3,49531,2)
 ;;=^5007176
 ;;^UTILITY(U,$J,358.3,49532,0)
 ;;=I35.9^^191^2468^18
 ;;^UTILITY(U,$J,358.3,49532,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49532,1,3,0)
 ;;=3^Nonrheumatic Aortic Vlve D/O,Unsp
 ;;^UTILITY(U,$J,358.3,49532,1,4,0)
 ;;=4^I35.9
 ;;^UTILITY(U,$J,358.3,49532,2)
 ;;=^5007178
 ;;^UTILITY(U,$J,358.3,49533,0)
 ;;=I42.7^^191^2468^3
 ;;^UTILITY(U,$J,358.3,49533,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49533,1,3,0)
 ;;=3^Cardiomyopathy d/t Drug/Extrn Agent
 ;;^UTILITY(U,$J,358.3,49533,1,4,0)
 ;;=4^I42.7
 ;;^UTILITY(U,$J,358.3,49533,2)
 ;;=^5007198
 ;;^UTILITY(U,$J,358.3,49534,0)
 ;;=I21.3^^191^2468^23
 ;;^UTILITY(U,$J,358.3,49534,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49534,1,3,0)
 ;;=3^STEMI,Unspec Site
 ;;^UTILITY(U,$J,358.3,49534,1,4,0)
 ;;=4^I21.3
 ;;^UTILITY(U,$J,358.3,49534,2)
 ;;=^5007087
 ;;^UTILITY(U,$J,358.3,49535,0)
 ;;=I25.5^^191^2468^17
 ;;^UTILITY(U,$J,358.3,49535,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49535,1,3,0)
 ;;=3^Ischemic Cardiomyopathy
 ;;^UTILITY(U,$J,358.3,49535,1,4,0)
 ;;=4^I25.5
 ;;^UTILITY(U,$J,358.3,49535,2)
 ;;=^5007115
 ;;^UTILITY(U,$J,358.3,49536,0)
 ;;=I25.9^^191^2468^6
 ;;^UTILITY(U,$J,358.3,49536,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49536,1,3,0)
 ;;=3^Chronic Ischemic Heart Disease,Unsp
 ;;^UTILITY(U,$J,358.3,49536,1,4,0)
 ;;=4^I25.9
 ;;^UTILITY(U,$J,358.3,49536,2)
 ;;=^5007144
 ;;^UTILITY(U,$J,358.3,49537,0)
 ;;=I25.10^^191^2468^2
 ;;^UTILITY(U,$J,358.3,49537,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49537,1,3,0)
 ;;=3^Athscl Hrt Dis Ntv Cor Art w/o Ang Pctrs
 ;;^UTILITY(U,$J,358.3,49537,1,4,0)
 ;;=4^I25.10
 ;;^UTILITY(U,$J,358.3,49537,2)
 ;;=^5007107
 ;;^UTILITY(U,$J,358.3,49538,0)
 ;;=D64.9^^191^2468^1
